Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Therapeutic Advances In Childhood Leukemia Consortium

Clinical trials sponsored by Therapeutic Advances In Childhood Leukemia Consortium, explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Completed 2

New drug combo aims to tame rare childhood leukemia

Disease control Recruiting now

This study tests a combination of two drugs, trametinib and azacitidine, for children newly diagnosed with juvenile myelomonocytic leukemia (JMML), a rare blood cancer. Lower-risk patients get just these two drugs, while higher-risk patients also receive standard chemotherapy. Th…

Phase: PHASE1, PHASE2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control

Last updated Jun 27, 2026 12:07 UTC